Document is current
Any future updates will be listed below
-
Authors
Xu, Tongzhen
Ma, Huiying
Zhang, Wenjue
Yang, Yongjing
Xiao, Weiwei
Li, Ning
Li, Haoyue
Gao, Yuanhong
Liu, Shixin
Wei, Lichun
Jiang, Liming
Shi, Jinming
Shuai, Jiacheng
Cai, Yong
Li, Yongheng
Cheng, Guanghui
Luo, WenGuang
Wang, Xin
Liu, Ke
Wang, Jun
Lu, Ningning
Fang, Hui
Liu, Yueping
Song, Yongwen
Zhang, Wenwen
Wang, Shulian
Li, Yexiong
Zhou, Aiping
Zhou, Haitao
Chi, Yihebali
Tang, Yuan
Jin, Jing
-
Funding
Funding for this research was provided by:
Shenzhen Medical Research Fund (C2301001)
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen (E010121001 and E010222001)
National High Level Hospital Clinical Research Funding and Cooperation Fund of CHCAMS Beijing & Langfang &SZCH (CFA202501001)
National Natural Science Foundation of China (82473248)
the Noncommunicable Chronic Diseases-National Science and Technology Major Project
- License Information
-
More Information
Article History
Received: 15 October 2025
Accepted: 16 February 2026
First Online: 25 February 2026
Declarations
:
: STELLAR was designed by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) in Beijing, China. Patients were enrolled from 16 hospitals in 11 provinces of China. All patients provided written informed consent. The protocol was approved by the local ethics committee and registered at ClinicalTrials.gov (identifier: NCT02533271).
: Not applicable.
: The authors declare no competing interests.
